508
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma

, &
Pages 705-715 | Received 01 Apr 2016, Accepted 18 May 2016, Published online: 10 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Weitian Hua, Xingfeng Huang, Jingyu Li, Wei Feng, Yi Sun & Chengrui Guo. (2022) 2-methoxyestradiol inhibits melanoma cell growth by activating adaptive immunity. Immunopharmacology and Immunotoxicology 44:4, pages 541-547.
Read now

Articles from other publishers (7)

Yanlin Song, Zhenfei Bi, Yu Liu, Furong Qin, Yuquan Wei & Xiawei Wei. (2023) Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials. Genes & Diseases 10:1, pages 76-88.
Crossref
Paolo A Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Jacob Schachter, Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Grant A McArthur & Ralf Gutzmer. (2023) Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study. The Lancet Oncology 24:1, pages 33-44.
Crossref
Camille Houron, Marie Danielou, Olivier Mir, Bernard Fromenty, Gabriel Perlemuter & Cosmin Sebastian Voican. (2021) Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians. Critical Reviews in Oncology/Hematology 157, pages 103127.
Crossref
Amanda J. Podolski & Rasim Gucalp. 2021. Geriatric Gastroenterology. Geriatric Gastroenterology 341 379 .
Amanda J. Podolski & Rasim Gucalp. 2020. Geriatric Gastroenterology. Geriatric Gastroenterology 1 39 .
Debora Basile, Camilla Lisanti, Maria A. Pizzichetta, Paolo Baldo, Giulia Fornasier, Francesco Lo Re, Giuseppe Corona & Fabio Puglisi. (2019) Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma. Recent Patents on Anti-Cancer Drug Discovery 14:3, pages 203-225.
Crossref
Silvia Méndez-MartínezPilar CalvoOscar Ruiz-MorenoNieves Pardiñas Barón, Jesús Leciñena Bueno, María del Rocío Gil Ruiz & Luis Pablo. (2019) OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS. Retina 39:8, pages 1435-1450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.